White label ELPA - ClinicalTrials.eu

Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Recruiting

3 1 1 1
Investigated drugs:
Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

Recruiting

1 1 1
Investigated diseases:
Investigated drugs:
- Ifinatamab Deruxtecan
+3
Study on Iberdomide, Cyclophosphamide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma refractory
Investigated drugs:
Study on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Colon cancer stage III
- Colon cancer stage IV
Investigated drugs:
Study on the Effectiveness and Safety of Fosmanogepix Compared to Caspofungin and Fluconazole for Adults with Candidemia or Invasive Candidiasis

Recruiting

3 1 1
Investigated diseases:
- Systemic candida
Investigated drugs:
+2
Study on Mitomycin and BCG for Patients with Recurrent Non-Muscle Invasive Bladder Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
- Mitomycin
Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis

Recruiting

1 1 1
Investigated diseases:
- Myelofibrosis
Investigated drugs:
- Momelotinib Dihydrochloride Monohydrate
+7
Study of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant

Recruiting

2 1 1 1
Investigated diseases:
- Acute lymphocytic leukaemia recurrent
Investigated drugs:
Study on the Safety and Effectiveness of CTX001 for Children with Severe Sickle Cell Disease Using Exagamglogene Autotemcel, Busulfan, and Plerixafor

Recruiting

3 1 1 1
Investigated diseases:
- Sickle cell anaemia
Investigated drugs:
Study of Nivolumab for Early Stage Hodgkin Lymphoma in Patients with Good Prognosis

Recruiting

2 1 1 1
Investigated diseases:
- Hodgkin’s disease
Investigated drugs:
- Nivolumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies